Source comparison
Melanotan-2 Dosage Erectile Function: Comparison Table
The following table compares Melanotan-2 dosing tiers for erectile function against key efficacy and safety markers based on clinical observations and user-reported data from research contexts. 0.25mg subcutaneous 2–3x weekly 15–20% report mild improvement Min
This comparison does not assign a generated winner or score.
- The following table compares Melanotan-2 dosing tiers for erectile function against key efficacy and safety markers based on clinical observations and user-reported data from research contexts.
- 0.25mg subcutaneous
- 2–3x weekly
- 15–20% report mild improvement
- Minimal. Occasional mild nausea
- 24–36 hours
- Too low for most users; useful only as titration starting point
- 0.5mg subcutaneous
- 40–50% report reliable spontaneous erections
- Mild nausea (20%), facial flushing (30%)
- 36–48 hours
- Optimal starting therapeutic dose; balance of efficacy and tolerability
- 1mg subcutaneous
- 65–70% report strong spontaneous and stimulation-based erections
- Moderate nausea (40%), flushing (60%), BP elevation 8–12 mmHg
- 48–72 hours
- Maximum recommended dose for most users; side effects become limiting above this
- 1.5mg+ subcutaneous
- 70–75% (marginal gain over 1mg)
- High nausea (60%), priapism risk 5–8%, significant BP elevation
- 72+ hours
- Not recommended; priapism risk outweighs marginal efficacy gain